HealthCare Global Enterprises Limited
NSE:HCG.NS
416 (INR) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 19,078.7 | 16,914.1 | 13,831.38 | 10,040.12 | 10,805.99 | 9,608.82 | 8,182.56 | 7,001.11 | 5,819.765 | 5,193.75 | 4,513.34 | 3,383.05 |
| Cost of Revenue
| 8,889.9 | 7,801.8 | 6,820.73 | 4,998.52 | 5,234.41 | 4,671.23 | 3,808.53 | 3,403.4 | 1,495.713 | 1,460.345 | 2,256.49 | 1,687.21 |
| Gross Profit
| 10,188.8 | 9,112.3 | 7,010.65 | 5,041.6 | 5,571.58 | 4,937.59 | 4,374.03 | 3,597.71 | 4,324.052 | 3,733.405 | 2,256.85 | 1,695.84 |
| Gross Profit Ratio
| 0.534 | 0.539 | 0.507 | 0.502 | 0.516 | 0.514 | 0.535 | 0.514 | 0.743 | 0.719 | 0.5 | 0.501 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 674.29 | 423.84 | 276.25 | 249.86 | 259.12 | 251.5 | 128.72 | 125.375 | 114.381 | 155.8 | 92.46 |
| Selling & Marketing Expenses
| 0 | 336.5 | 181.06 | 135.74 | 193.26 | 121.93 | 100.61 | 105.07 | 95.57 | 139.446 | 98.42 | 67.27 |
| SG&A
| 3,853 | 1,010.79 | 604.9 | 411.99 | 443.12 | 381.05 | 352.11 | 233.79 | 125.375 | 114.381 | 254.22 | 159.73 |
| Other Expenses
| 169.4 | 131.8 | 4.95 | 11.88 | 11.38 | 30.33 | 33.3 | 9.6 | 11.532 | 11.971 | 0 | 0 |
| Operating Expenses
| 8,636.5 | 7,760.2 | 6,236.2 | 5,367.45 | 5,309.13 | 4,535.68 | 3,799.91 | 3,115.41 | 3,869.512 | 3,362.834 | 2,239.04 | 1,529.8 |
| Operating Income
| 1,725.6 | 1,355.25 | 795.46 | -333.74 | 229.47 | 396.09 | 574.12 | 482.3 | 454.54 | 370.571 | 27.79 | 170.57 |
| Operating Income Ratio
| 0.09 | 0.08 | 0.058 | -0.033 | 0.021 | 0.041 | 0.07 | 0.069 | 0.078 | 0.071 | 0.006 | 0.05 |
| Total Other Income Expenses Net
| -1,048.4 | -906.45 | 82.26 | -1,952.89 | -1,422.11 | -729.84 | -302.36 | -133.87 | -404.521 | -340.43 | -294.31 | -272.02 |
| Income Before Tax
| 677.2 | 448.7 | 877.72 | -2,286.63 | -1,192.64 | -333.75 | 271.76 | 348.43 | 50.019 | 30.141 | -266.52 | -101.45 |
| Income Before Tax Ratio
| 0.035 | 0.027 | 0.063 | -0.228 | -0.11 | -0.035 | 0.033 | 0.05 | 0.009 | 0.006 | -0.059 | -0.03 |
| Income Tax Expense
| 264 | 272.5 | 488.47 | -75.61 | 61.89 | -25 | 102.38 | 118 | -4.316 | -16.828 | 53.52 | 7.14 |
| Net Income
| 481.4 | 293.4 | 537.33 | -1,934.61 | -1,066.95 | -247.97 | 205.23 | 221.73 | 12.205 | 8.34 | -355.53 | -105.14 |
| Net Income Ratio
| 0.025 | 0.017 | 0.039 | -0.193 | -0.099 | -0.026 | 0.025 | 0.032 | 0.002 | 0.002 | -0.079 | -0.031 |
| EPS
| 3.46 | 2.11 | 4.14 | -17.02 | -12.05 | -2.82 | 2.39 | 2.69 | -2.43 | 0.12 | -5.18 | -1.74 |
| EPS Diluted
| 3.43 | 2.1 | 3.97 | -17.02 | -12.05 | -2.81 | 2.38 | 2.69 | -2.43 | 0.11 | -5.18 | -1.74 |
| EBITDA
| 3,469.2 | 3,118.4 | 2,283.48 | 1,212.12 | 1,558.12 | 1,025.24 | 1,344.48 | 1,094.16 | 884.066 | 792.483 | 389.55 | 466.31 |
| EBITDA Ratio
| 0.182 | 0.184 | 0.165 | 0.121 | 0.144 | 0.107 | 0.164 | 0.156 | 0.152 | 0.153 | 0.086 | 0.138 |